Elevated uric acid levels are associated with increased risks for hypertension, gout, and renal impairment.
Many but not all cohort studies examining the relationship between hyperuricemia and CKD outcomes suggest they may be intertwined.
Allopurinol therapy is not associated with beneficial cardiovascular outcomes in gout patients.
In a study, donors were 60% more likely to be diagnosed with gout than matched healthy controls.
Likelihood of a recurrent gout attack is greater under conditions of high temperature and/or low relative humidity.
Renal function decline is not accelerated, however.
Korean study also revealed an inverse association between serum homocysteine levels and renal function.
An Israeli study shows that serum uric acid levels can be a clinically useful nutritional marker.
Patients with hyperuricemia who use urate-lowering therapies are less likely to experience renal function decline.
A level of 7 mg/dL or higher is associated with a 62% increased risk compared with lower levels.
Elevated levels of uric acid are associated with an increased likelihood of diabetes.
Patients with coronary artery disease are more likely to have ED if they have elevated uric acid levels.
After diabetes is diagnosed, however, uric acid levels fall, study finds.
Serum level before procedure is an independent predictor of stent restenosis.
Individuals with first-degree relatives affected by the condition are twice as likely as those in the general population to experienced gout.
Patients with hyperuricemia also had a high prevalence of lower urinary tract symptoms.
Elevated uric acid levels are associated with increased risk of ischemic heart disease and blood pressure, but appear unlikely to cause these problems, a study found.